UNSPSC 51402303: Enpiprazole

This classification denotes an anxiolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78G92X9EH7. European Medicines Agency schedules Enpiprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06544MIG. Enpiprazole generally arises in the molecular formula C16H21CLN4.

UNSPSC 51402303 Enpiprazole is a Commodity code that currently shows minimal alignment with recent state and local procurement activity. The single recent opportunity tagged under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems, not enpiprazole, a pharmaceutical compound used primarily in gastroenterology and research settings. The mismatch suggests either a coding error in the county's procurement system or that the code is not actively used for its intended pharmaceutical purpose in the state and local market. Seminole County's procurement is driven by community health initiatives and opioid-response programs, with an annual requirement for 1,900 units of naloxone and 800 safe drug deactivation systems, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida. The county's IFB process requires electronic submission, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, and maintains an initial two-year term with one-year renewal option. The procurement does not specify set-aside designations and is potentially FEMA-funded, introducing federal compliance requirements.

Based on the single available record, the code does not currently reflect active state and local procurement for enpiprazole or related pharmaceutical products. Seminole County, Florida, is the only recent issuer, and the activity under this code is dominated by naloxone procurement rather than the pharmaceutical compound the code nominally describes. The response deadline for Seminole County's opportunity was July 26, 2023, making this record substantially outdated relative to current procurement cycles. Business development professionals should verify whether opportunities coded to this commodity actually require enpiprazole or similar agents before investing in pursuit strategy; the current taxonomy usage does not support reliable market activity under the code's intended scope.